The medical device supplier is charged with fraudulently submitting millions of dollars in billing for devices that were not necessary, covered, or agreed to by patients.
Legislators continue to introduce bills to limit AI-generated healthcare decisions, even as the U.S. Attorney General has been instructed to oppose them.
Using data from 2 million claims across 32 states, the study found that the prevalence of these surgeries increased, driven by shoulder joint replacements.
While AI can be effective in some elements of drug design, AI models currently struggle to explain their decision making, a key component of drug review.
